Verastem Oncology, Inc. (NASDAQ: VSTM) has added another regulatory milestone for VS 7375, a drug still in early testing but now carrying a second Fast...
Lung Cancer
Oncology drug development is entering a phase where the most interesting questions are not just about whether a therapy can shrink a tumor, but about...
